Is InMed Pharmaceuticals Inc halal to invest in?

According to Musaffa's Shariah screening methodology, InMed Pharmaceuticals Inc (INM) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is InMed Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes InMed Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of InMed Pharmaceuticals Inc?

Muslim investors may consider investing in InMed Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is InMed Pharmaceuticals Inc classified as NOT HALAL?

Musaffa determines the Shariah status of InMed Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for InMed Pharmaceuticals Inc updated?

The Shariah compliance status of InMed Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like InMed Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of InMed Pharmaceuticals Inc?

You can check the latest Shariah compliance status of InMed Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

INM Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 13, 2026

Report Source: 2026 2nd Quarter Report

InMed Pharmaceuticals Inc. Stock Analysis INM

United States Health Care Nano Cap Report: Q2, 2026

InMed Pharmaceuticals, Inc. engages in developing small molecule drug candidates targeting the CB1/CB2 receptors. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-06-21. The firm develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharma segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is a small molecule drug candidate being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.

Key Statistics of InMed Pharmaceuticals Inc (INM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.64$0.68

Today's Open

$0.66

Volume

10.78K

P/E Ratio (TTM)

52 Week Range

$0.58$7.98

Market Cap

2.45M

Avg. Volume

26.03K

Dividend Yield

Financial Metrics & Statements of InMed Pharmaceuticals Inc (INM)

FAQ's for InMed Pharmaceuticals Inc (INM)

According to Musaffa’s Shariah screening methodology, InMed Pharmaceuticals Inc (INM) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.